Quantum Computers Show Big Leap in Protein Study

IBM presented a new step for quantum machines, showing a protein simulation that is 210 times more precise than older methods. The announcement came during its Think 2026 conference, where the company highlighted how quantum and regular computers can collaborate. Instead of forcing classical machines to mimic natural quantum behavior, IBM pairs the two systems so each does what it does best. A team from the Cleveland Clinic and RIKEN used IBM’s hardware to model a protein complex containing 12, 635 atoms. The goal was to see how a drug‑like molecule fits onto the protein surface, a key part of discovering new medicines. Because the hybrid approach produced results 210 times closer to reality than previous attempts, IBM says it proves quantum computing can tackle problems that normal computers find hard.The company also showed progress in studying materials with Q‑CTRL on its quantum platform. A simulation of up to 60 interacting electrons ran in about two minutes, whereas the same calculation would take roughly 100 hours on a conventional machine. The quantum method stayed within one percent of the expected accuracy, demonstrating speed without sacrificing quality. Wall Street analysts have mixed feelings about IBM’s stock. Recent ratings show a majority of “Buy” opinions, with an average price target suggesting about 28 percent upside potential. The company’s financial outlook remains uncertain as it balances research investments with market performance.